Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT-PGTT: Pharmacogenomics-based Isoniazid for TB
NCT00298870Phase 4Completed
- Sponsor
- The University of Osaka
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of isoniazid in pulmonary tuberculosis (TB) (2 arms), sponsored by The University of Osaka. Primary endpoint: The incidences of unfavorable events in two different treatment regimens based on the NAT2 gene polymorphism. Started Jun 2005; status: completed.
02
Drugs
isoniazid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00298870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298870.